These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19413181)

  • 1. Should D-dimer testing be used to predict the risk of recurrence after discontinuation of anticoagulant therapy for a first unprovoked episode of venous thromboembolism?
    Wu C; Bates SM
    Pol Arch Med Wewn; 2009 Apr; 119(4):225-30. PubMed ID: 19413181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism.
    Verhovsek M; Douketis JD; Yi Q; Shrivastava S; Tait RC; Baglin T; Poli D; Lim W
    Ann Intern Med; 2008 Oct; 149(7):481-90, W94. PubMed ID: 18838728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How D-dimer assay can be useful in deciding the duration of anticoagulation after venous thromboembolism: a review.
    Palareti G
    Expert Rev Hematol; 2015 Feb; 8(1):79-88. PubMed ID: 25348806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d-dimer results; A cohort study.
    Kearon C; Parpia S; Spencer FA; Schulman S; Stevens SM; Shah V; Bauer KA; Douketis JD; Lentz SR; Kessler CM; Connors JM; Ginsberg JS; Spadafora L; Julian JA
    J Thromb Haemost; 2019 Jul; 17(7):1144-1152. PubMed ID: 31033194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study.
    Kearon C; Spencer FA; O'Keeffe D; Parpia S; Schulman S; Baglin T; Stevens SM; Kaatz S; Bauer KA; Douketis JD; Lentz SR; Kessler CM; Moll S; Connors JM; Ginsberg JS; Spadafora L; Julian JA;
    Ann Intern Med; 2015 Jan; 162(1):27-34. PubMed ID: 25560712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
    Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
    Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "HERDOO2" clinical decision rule to guide duration of anticoagulation in women with unprovoked venous thromboembolism. Can I use any d-Dimer?
    Rodger MA; Le Gal G; Langlois NJ; Gin B; Mallick R; Giulivi A; Freedman M; Kovacs MJ;
    Thromb Res; 2018 Sep; 169():82-86. PubMed ID: 30031290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH).
    Tosetto A; Iorio A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Douketis J
    J Thromb Haemost; 2012 Jun; 10(6):1019-25. PubMed ID: 22489957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-dimer levels during and after anticoagulation withdrawal in patients with venous thromboembolism treated with non-vitamin K anticoagulants.
    Legnani C; Martinelli I; Palareti G; Ciavarella A; Poli D; Ageno W; Testa S; Mastroiacovo D; Ciammaichella M; Bucherini E; Mumoli N; Cosmi B
    PLoS One; 2019; 14(7):e0219751. PubMed ID: 31310608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal long-term pharmacological treatment of patients with venous thromboembolism that was unprovoked or associated with weak risk factors.
    Palareti G
    Expert Rev Hematol; 2017 Oct; 10(10):921-931. PubMed ID: 28803491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The optimal duration of anticoagulant therapy after unprovoked venous thromboembolism - still a challenging issue.
    Elmi G; Di Pasquale G; Pesavento R
    Vasa; 2017 Mar; 46(2):87-95. PubMed ID: 28102773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal duration of anticoagulation in patients with unprovoked venous thromboembolism: the impact of novel anticoagulants.
    Prandoni P; Milan M; Sarolo L; Zanon E; Bilora F
    Int Angiol; 2017 Oct; 36(5):395-401. PubMed ID: 27982558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of D-Dimer Testing in Predicting Recurrence in Elderly Patients with Unprovoked Venous Thromboembolism.
    Tritschler T; Limacher A; Méan M; Rodondi N; Aujesky D
    Am J Med; 2017 Oct; 130(10):1221-1224. PubMed ID: 28522384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
    Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
    Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulodexide for the Prevention of Recurrent Venous Thromboembolism: The Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
    Andreozzi GM; Bignamini AA; Davì G; Palareti G; Matuška J; Holý M; Pawlaczyk-Gabriel K; Džupina A; Sokurenko GY; Didenko YP; Andrei LD; Lessiani G; Visonà A;
    Circulation; 2015 Nov; 132(20):1891-7. PubMed ID: 26408273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long term.
    de Jong PG; Coppens M; Middeldorp S
    Br J Haematol; 2012 Aug; 158(4):433-41. PubMed ID: 22734929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study.
    Cosmi B; Legnani C; Iorio A; Pengo V; Ghirarduzzi A; Testa S; Poli D; Tripodi A; Palareti G;
    Eur J Vasc Endovasc Surg; 2010 Mar; 39(3):356-65. PubMed ID: 20034816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism: risk factors for recurrence.
    Zhu T; Martinez I; Emmerich J
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-dimer levels and recurrence in patients with unprovoked VTE and a negative qualitative D-dimer test after treatment.
    Kearon C; Parpia S; Spencer FA; Baglin T; Stevens SM; Bauer KA; Lentz SR; Kessler CM; Douketis JD; Moll S; Kaatz S; Schulman S; Connors JM; Ginsberg JS; Spadafora L; Liaw PC; Weitz JI; Julian JA
    Thromb Res; 2016 Oct; 146():119-125. PubMed ID: 27354153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-dimer levels over time and the risk of recurrent venous thromboembolism: an update of the Vienna prediction model.
    Eichinger S; Heinze G; Kyrle PA
    J Am Heart Assoc; 2014 Jan; 3(1):e000467. PubMed ID: 24385451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.